LINDSEY HENLEY: Open Payments
NPI 1952882698 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 86 payments from 15 companies in 2025. Trend: 2023 $1,313 · 2024 $1,989 · 2025 $1,696
Food & beverage: $1,696
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $365 |
| ABBVIE INC. | 23 | $321 |
| Janssen Biotech, Inc. | 7 | $256 |
| Madrigal Pharmaceuticals | 5 | $117 |
| Novo Nordisk Inc | 4 | $106 |
| Lilly USA, LLC | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Ardelyx, Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $37 |
Products named: TREMFYA, XELJANZ, VELSIPITY, DUPIXENT, LINZESS, REZDIFFRA, OMVOH, Wegovy.
Industry payments across NC — which companies pay providers there.
